These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2864975)

  • 1. Muscarinic receptors discriminated by pirenzepine are involved in the regulation of neurotransmitter release in rat nucleus accumbens.
    de Belleroche J; Gardiner IM
    Br J Pharmacol; 1985 Oct; 86(2):505-8. PubMed ID: 2864975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Ichikawa J; Chung YC; Li Z; Dai J; Meltzer HY
    Brain Res; 2002 Dec; 958(1):176-84. PubMed ID: 12468043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic action in the nucleus accumbens: modulation of dopamine and acetylcholine release.
    de Belleroche JS; Gardiner IM
    Br J Pharmacol; 1982 Feb; 75(2):359-65. PubMed ID: 7186823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
    Bymaster FP; Heath I; Hendrix JC; Shannon HE
    J Pharmacol Exp Ther; 1993 Oct; 267(1):16-24. PubMed ID: 7901390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
    Kenakin T; Boselli C
    J Pharmacol Exp Ther; 1989 Sep; 250(3):944-52. PubMed ID: 2778720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presynaptic muscarinic receptors on dopaminergic terminals in the nucleus accumbens.
    De Belleroche J; Kilpatrick IC; Birdsall NJ; Hulme EC
    Brain Res; 1982 Feb; 234(2):327-37. PubMed ID: 7059834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
    el-Fakahany EE; Ramkumar V; Lai WS
    J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic characterization and functional role of muscarinic autoreceptors in the rabbit striatum.
    James MK; Cubeddu LX
    J Pharmacol Exp Ther; 1987 Jan; 240(1):203-15. PubMed ID: 3806384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscarine receptor-mediated modulation of [3H]dopamine and [14C]acetylcholine release from rat neostriatal slices: selective antagonism by gallamine but not pirenzepine.
    Schoffelmeer AN; Van Vliet BJ; Wardeh G; Mulder AH
    Eur J Pharmacol; 1986 Sep; 128(3):291-4. PubMed ID: 3792444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats.
    Xu M; Mizobe F; Yamamoto T; Kato T
    Brain Res; 1989 Aug; 495(2):232-42. PubMed ID: 2765928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selectivity profile of the novel muscarinic antagonist UH-AH 37 determined by the use of cloned receptors and isolated tissue preparations.
    Wess J; Lambrecht G; Mutschler E; Brann MR; Dörje F
    Br J Pharmacol; 1991 Jan; 102(1):246-50. PubMed ID: 2043926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of muscarinic receptors in the activation of the ventral subiculum and the consequences for dopamine release in the nucleus accumbens.
    Moss S; Sharott A; Goodhead LH; Mitchell SN
    Eur J Pharmacol; 2003 Jan; 460(2-3):117-25. PubMed ID: 12559371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic receptor blockade increases basal acetylcholine release from striatal slices.
    Dolezal V; Wecker L
    J Pharmacol Exp Ther; 1990 Feb; 252(2):739-43. PubMed ID: 2313598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase.
    Gil DW; Wolfe BB
    J Pharmacol Exp Ther; 1985 Mar; 232(3):608-16. PubMed ID: 2579230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH; el-Fakahany EE
    J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intracerebroventricular pirenzepine on muscarinic discriminations in rats.
    Jung M; Perio A; Terranova JP; Worms P; Biziere K
    Eur J Pharmacol; 1987 Jul; 139(1):111-6. PubMed ID: 3653237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
    Flynn DD; Mash DC
    J Pharmacol Exp Ther; 1989 Aug; 250(2):573-81. PubMed ID: 2760841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective antagonism by pirenzepine and N-methyl-scopolamine on muscarinic receptor subtypes of the rat vas deferens.
    Miranda HF; Silva WI; Wolstenholme WW; Cuevas N
    Gen Pharmacol; 1988; 19(3):417-20. PubMed ID: 3417103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcholine acts on m2-muscarinic receptors to excite rat locus coeruleus neurones.
    Egan TM; North RA
    Br J Pharmacol; 1985 Aug; 85(4):733-5. PubMed ID: 3840044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related differences in the effects of some muscarinic agents on acetylcholine release from rat neostriatal slices.
    Lee HJ; Cozzi NV; Weiler MH
    J Pharmacol Exp Ther; 1991 Aug; 258(2):496-501. PubMed ID: 1865353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.